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Abstract
Background: Oxidative stress is implicated in the pathogenesis of migraine, but no published studies have examined
both oxidative stress levels and oxidative DNA damage on the same patient group.
Methods: In this study, total oxidant status (TOS); total antioxidant status (TAS); oxidative stress index (OSI); and
8-hydroxy-2′-deoxyguanosine (8-OHdG), which is an indicator of oxidative DNA damage, were measured in
the plasma samples of 50 prophylactic unmediated migraineurs (11 with aura and 39 without aura) and 30 matched
healthy volunteers.
Results: No significant differences in TAS, TOS, and OSI values were observed between patients and controls. However,
plasma 8-OHdG levels were found to be significantly higher in migraine patients than in the control group (p = 0.001);
this increase in plasma 8-OHdG levels was more prominent in cases with migraine without aura than with aura
(p = 0.001). Our results suggested an evidence of oxidative stress-related DNA damage in migraine.
Conclusion: DNA damage reflected by plasma 8-OHdG did not studied in migraine before. Therefore, further
research on oxidative stress-related DNA damage and the extent of its clinical manifestations in migraine may
provide additional data to our current knowledge.
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Background
Oxidative stress, which arises because of an imbalance
between the production of reactive oxygen species (ROS)
and elimination by antioxidant defense mechanisms, has
been implicated in various headache disorders [1–3]
including migraine [4, 5]. Endogenous ROS can cause
oxidative damage to DNA, lipids, and proteins [6]. Oxi-
dants may also confer susceptibility to other pathogenic
processes by disrupting the functions of cytoprotective
proteins, such as metabolic enzymes and cell membrane
transporters [7]. Among the DNA constituents, guanine
has the lowest ionization potential; therefore, it is highly
susceptible to the actions of free radicals. The oxidation
product, 8-hydroxy-2′-deoxyguanosine (8-OHdG) gener-
ated by the hydroxylation of guanine at the C8 position is
one of the most common biomarkers used to detect oxi-
dative DNA base damage induced by ROS [8]. It is also
used as a marker of oxidative stress, mitochondrial dysfunc-
tion, and impaired metabolism [9]. Subsequent to oxida-
tion, damaged DNA is repaired by cellular mechanisms and
hydroxylated guanine is eliminated in body fluids [8, 10].
Many studies have been conducted to elucidate the
pathophysiology of migraine. However, it is currently not
possible to explain the etiopathogenesis of the disease by
a single theory. Recent studies supported the potential
role of oxidative stress and related structures [11–13],
but, to the best of our knowledge, no published study has
simultaneously investigated oxidative stress parameters
and oxidative DNA damage indicators on the same group
of patients with migraine.
In the present study, we aimed to evaluate the plasma
total oxidant status (TOS); plasma total antioxidant status
(TAS); oxidative stress index (OSI); and 8-hydroxy-2′-
deoxyguanosine (8-OHdG), which is an indicator of
oxidative DNA damage, in patients with migraine in
the interictal phase, taking into account the different
subgroups of patients with and without aura.
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We assessed the intergroup differences and the effects
of demographic, clinical, and laboratory characteristics




Study approval was obtained from the Ethics Committee
of Gaziantep University Faculty of Medicine (24.3.2014/
106). Informed consent was obtained from all subjects
prior to the study. This study examined 50 consecutive
patients aged 18–45 years, who were diagnosed to have
migraine and were not on prophylactic treatment for at
least 3 months and for at least 72 h symtomathic drug-
free period before obtaining blood samples in the inter-
ictal phase. Migraine, both with and without aura, was
diagnosed according to the ICHD-3 beta criteria [14] by
a single experienced neurologist in our clinic and then
enrolled to the study. The control group (n = 30) was
composed of healthy health care workers and medical
students who worked in our hospital, met the criteria for
joining the study, signed informed consent form and
matched with the patient group with respect to age and
sex. Cases with moderate or severe mental retardation;
history of significant head trauma; malnutrition; pregnancy;
diabetes mellitus (fasting blood glucose ≥ 120 mg/dl);
hypertension (BP ≥ 140/90 mmHg); chronic renal failure;
liver cirrhosis; any type of cancer; thyroid diseases; alcohol
and substance abuse; chronic neurologic illnesses, includ-
ing epilepsy, Parkinson’s disease, Huntington’s disease,
Alzheimer’s disease, Wilson’s disease, and previous
cerebrovascular disease; morbid obesity; and any exist-
ing infection were excluded from both groups. Other
exclusion criteria were the use of glucocorticoids; oral
contraceptives; antioxidant agents, such as vitamin E,
vitamin C, or N-acetylcysteine; and xanthine oxidase
inhibitors, such as allopurinol or folic acid.
The medical history, physical and neurologic examin-
ation findings, and body mass index (BMI) of all cases
were recorded on a previously structured form. The mi-
graine characteristics, such as type, frequency within the
last 3 months, associated features, etc., were also recorded
for the migraine group. Routine laboratory examinations,
including total blood count, serum electrolytes, serum cre-
atinine, blood urea nitrogen (BUN), fasting blood glucose
levels, and liver function tests, were performed in all cases.
The Migraine Disability Assessment Scale (MIDAS) was
used to assess the severity of migraine in the migraine
group.
Blood sampling
Venous blood samples were drawn from the antecubital
vein in the morning hours after 12 h of fasting and for
at least 72 h without symtomethic migraine medication.
Plasma was separated from blood samples into plain bio-
chemistry tubes by centrifugation at 3000 rpm for 5 min
at 4 °C. Plasma samples were stored at −80 °C until the
measurement of total antioxidant status (TAS), total oxi-
dant status (TOS), and 8-OHdG.
Measurement of study variables
Plasma TAS and TOS were measured by a fully auto-
mated colorimetric assay developed by Erel [15, 16].
Fe2+–o-dianisidine complex gave a Fenton-type reaction
with hydrogen peroxide to form the OH radical. This
powerful ROS reacted with the colorless o-dianisidine
molecule at a reducing low pH to form yellow–brown dia-
nisidyl radicals. Dianisidyl radicals participated in further
oxidation reactions, resulting in a more color formation.
The antioxidants in the samples suppressed these oxi-
dation reactions and inhibited color formation; this reac-
tion was measured spectrophotometrically by automatic
analyzers. According to this method thiol groups are re-
sponsible 52.9 % and uric asit is responsible 33.1 % of the
total antioxidant capacity of healthy individuals [17]. The
oxidants in the sample converted the Fe2+–o-dianisidine
complex to ferric ion; glycerol in the media accelerated
this reaction by about 3-fold. The ferric ions formed a col-
ored compound with xylenol orange in the acidic media;
this color was associated with the amount of oxidants in
the sample and was spectrophotometrically measured. In
this method Total Oxidant Status refers mostly to plasma
levels of hydrogen peroxide and lipid hydroperoxides. [16].
The ratio of plasma TOS to TAS levels was deter-
mined as the oxidative stress index (OSI). Serum levels
of 8-OHdG were measured using the Northwest kit
(NWLSS 8-OHdG ELISA High Sensitivity kit, Northwest;
Vancouver, Canada), a competitive ELISA kit suitable
for the quantification of DNA oxidation in tissues, serum,
and plasma.
Statistical analyses
The Kolmogorov–Smirnov test was used to check whether
continuous variables conformed to normal distribution.
Student’s t-test was used for the pair-wise comparison of
normally distributed data sets. The Mann–Whitney U test
was used for the pair-wise comparison of non-normally
distributed datasets. Categorical variables were compared
using the chi-square test and the coefficient of correlation
was used to test the strength of association between nu-
merical variables. Values were expressed as mean ± stand-
ard deviation (SD). SPSS for Windows version 22.0 (IBM
Corp., USA) was used for statistical analyses and p < 0.05
was considered statistically significant.
Results
The demographic characteristics of the study population
are shown in Table 1. The patient and control groups
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did not significantly differ in sex, mean age, mean BMI,
and smoking status (p > 0.05). Twenty-six (52 %) mi-
graine patients were using symptomatic drugs (triptans,
NSAID, paracetamol and combination analgesic). Out of
the 50 migraine cases, 11 had MWA and 39 had
MWoA. The subgroup comparison of the patient group
is presented in Table 2. There were no significant differ-
ences in the frequency of migraine attacks, duration of
disease, age at onset, and MIDAS scores between the
MWA and MWoA groups (p > 0.05).
Migraineurs showed no significant differences in TAS,
TOS, and OSI values compared with the controls (p > 0.05)
(Table 3). However, serum 8-OHdG was significantly
higher in patients with migraine than in healthy controls
(p = 0.001) (Table 3) (Fig. 1). TAS, TOS, and OSI did not
significantly differ between the MWA and MWoA patient
subgroups (p > 0.05), but plasma 8-OHdG was signifi-
cantly higher in MWoA patients (p = 0.001) (Table 4).
TAS and TOS levels did not differ by gender, by smoking
status or by symptomatic medication although 8-OHdG
was significantly higher in patient group than healty group
accordingly all of these variables (Table 5).
Disease duration or frequency of attacks and MIDAS
score were not significantly correlated with TAS, TOS,
OSI and 8-OHdG levels (Table 6). For the entire mi-
graine group, there was no significant correlation among
8-OHdG levels and TOS, TAS, OSI; whereas in the sub-
group comparison, 8-OHdG levels were positively corre-
lated with TOS and OSI in the MWoA group (r = 0.344,
p = 0.032) (Fig. 2).
Discussion
The present study revealed significantly high plasma levels
of 8-OHdG, an indicator of oxygen radical-induced DNA
damage, in migraine patients, which was more prominent
in MWoA cases. However, plasma TOS and TAS levels,
and OSI of migraine patients were statistically similar to
that of the control group.
Migraine is defined as a neurovascular disorder that
involves spreading cortical depression, neurogenic inflam-
mation, and dysfunction in cranial vascular contractility
[18]. Noxious free radicals produced as a result of meta-
bolic and physiologic processes are normally neutralized
by enzymatic and non-enzymatic antioxidant systems. The
balance can shift towards a state of oxidative stress due to
an increased production of free radicals or a deficiency in
antioxidant defense mechanisms [15]. Oxidative stress
can damage membrane lipids, nucleic acids, proteins, and
extracellular matrix components, including proteoglycans
and collagens [19]. Plasma 8-OHdG reflects oxidative
damage induced by free radicals to nuclear and mito-
chondrial DNA [8].
The role of oxidative stress in migraine was discussed
in various studies [4, 20, 21]. In Eren et al. study, no differ-
ence was found in TAS, TOS, OSI between the migraine
patients and controls. The level of thiol which created the
52.9 % of TAS was significantly lower in patients than in
controls. The results of our present study are compatible
with this study in terms of TAS, TOS and OSİ. [5],
whereas contradictory the results of Alp et al. study in
which they suggested that the levels of TAS were de-
creased and the levels of TOS and OSİ were increased
in patients with MWoA [20]. These conflicting results
may be because of the various techniques used, the bio-
logical samples analyzed, timing of sampling, and dif-
ferences in subject selection.
Both TOS and TAS have been shown to be reliable and
sensitive indicators of the current oxidant-antioxidant situ-
ation in the body at a given time. However, similar to the
others that are used to evaluate oxidative stress status, both
of these parameters may vary according to factors, such as
used technique, sampling hours in the day, physiologic and
Table 1 Demographic characteristics of the study population
Parameter Controls (n = 30) Patients (n = 50) p
Mean age (years) 29.60 ± 5.46 31.78 ± 5.81 0.101
Gender (n, %)
Female 19 (63.3) 36 (72.0) 0.418
Male 11 (36.7) 14 (28.0)
BMI (kg/m2) 23.19 ± 2.37 22.63 ± 2.74 0.357
Smoking (n, %) 18 (60.0) 35 (70.0) 0.360
BMI body mass index






Age at disease onset (years) 23.58 ± 4.2 21.12 ± 5.6 0.240
Duration of disease (years) 9.72 ± 6.29 7.66 ± 4.85 0.249
Frequency of attacks (within
the last 3 months)
2.18 ± 0.98 4.51 ± 4.04 0.363
Vomiting during attacks (n, %) 4 (36.4) 22 (56.4) 0.240
Mood changes (n, %) 10 (90.9) 37 (94.9) 0.625
MİDAS score 2.36 ± 1.20 2.92 ± 1.10 0.146
MWA migraine with aura, MWoA migraine without aura, MIDAS Migraine
Disability Assessment Scale
Table 3 Analysis of oxidative stress parameters in patients with
migraine
Parameter Patients (n = 50) Controls (n = 30) p value
TAS (mmolTroloxEqv/L)
(mean ± SD)
1.89 ± 0.16 1.90 ± 0.20 0.862
TOS (mmolTroloxEqv/L)
(mean ± SD)
4.96 ± 3.37 3.99 ± 3.09 0.080
OSI (mean ± SD) 0.25 ± 0.17 0.20 ± 0.15 0.110
8-OHdG (ng/mL)
(mean ± SD)
4.07 ± 1.24 3.16 ± 0.93 0.001*
Values are expressed as mean ± SD; TAS total antioxidant status, TOS total
oxidant status, OSI oxidative stress index, 8-OHdG 8-hydroxy-2′-deoxyguanosine
SD Standard deviation *p < 0.05
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pathologic events in the body, current drug intake, patient
habits, etc. Therefore, it is not easy to claim that all of the
findings regarding the oxidative stress parameters are
merely linked to the specific disease that is in the interest of
research in this area. This is true even for the studies that
were designed in the consideration of all parameters men-
tioned above, as was in this study. Further, we believe that
it would be more difficult to make such recommendations
for cases of paroxysmal disorders such as migraine. Even if
the phase of migraine (with or without attack) is controlled
in a study design, researchers may not be able to completely
homogenize the study population. On the other hand, the
consequences of oxidative stress, even in paroxysmal disor-
ders, may be more easily and stably detected in a wider
time interval. This point of view may possibly explain our
results. Although to decrease this possibility we preferred
to take the blood samples in the interictal phase from all of
the patients. Smoking, sex, symptomatic medication use are
other factors that can affect the oxidative stress status.
Higher levels of MDA, 8-OHdG, SOD and GSH-Px have
been shown in smokers [22]. Bloomer et al. suggested that
oxidative stress was lower in women than in men [23].
Orhan et al. suggested that NSAIDs and paracetamol may
involve in oxidative/antioxidative processes in the body dir-
ectly or indirectly [24]. Therefore to minimize these effects,
variables were matched in both groups and the blood sam-
ples were taken for at least 72 h drug-free period. In our re-
sults smoking, sex and symptomatic medication use did
not affect the comprasion of TOS, TAS and 8-OHdG levels
between groups.
Fig. 1 Serum concentrations of 8-OHdG, TAS, TOS and OSİ in migraine and healthy control groups
Table 4 Comparison of oxidative stress parameters according
to the type of migraine
Parameter MWA (n = 11) MWoA (n = 39) p value
TAS (mmolTroloxEqv/L)
(mean ± SD)
1.87 ± 0.17 1.89 ± 0.16 0.582
TOS (mmolTroloxEqv/L)
(mean ± SD)
4.76 ± 4.29 5.02 ± 3.13 0.178
OSI (mean ± SD) 0.25 ± 0.22 0.26 ± 0.16 0.313
8-OHdG (ng/mL)
(mean ± SD)
3.11 ± 0.65 4.34 ± 1.24 0.001*
Values are expressed as mean ± SD
MWA migraine with aura, MWoA migraine without aura, TAS total antioxidant
status, TOS total oxidant status, OSI oxidative stress index, 8-OHdG 8-hydroxy-
2′-deoxyguanosine, SD Standard deviation *p < 0.05
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Increased levels of 8-OHdG have been shown in stud-
ies on oxidative stress-related disorders [25–27], but the
exact biological role of 8-OHdG has been still unknown.
In this study, confounding factors that determine natural
antioxidant enzyme capacity, such as SOD, were not
accounted for and could have affected the serum 8-
OHdG levels. Nevertheless, the similar TAS levels in
both our study groups revealed that total antioxidant
capacity was not defective in migraine cases. Altought
plasma thiol groups might not adequately reflect redox
status in other tissues, such as the brain [28].
One interesting point in the present study was that the
plasma 8-OHdG levels were significantly higher in MWoA
than in MWA. Although there were no significant differ-
ences in terms of clinical characteristics of the subgroups,
the frequency of attacks and MIDAS scores were higher in
MWoA patients. Therefore, higher levels of 8-OHdG may
be related to the more severe and frequent attacks but not
to the type of migraine.
The relatively small number of patients in both mi-
graine groups, particularly in the MWA group, limits
the reliability of oxidative stress parameters comparison
between patients with or without aura. Our results
should be verified by further studies. We think these are
just preliminary results. Nevertheless, all biochemical as-
sessments of TOS, TAS, and OSI were done in the same
session by experienced experts in the same laboratory.
Therefore, the probability of technical error was low in
the present study. However, because there have been no
other studies that had a similar design to ours, we can-
not claim that TAS and TOS plasma levels and OSI are
the most suitable indicators of the relationship between
oxidative stress and its consequences, such as DNA
damage.
Conclusion
Therefore, further research on oxidative stress-related
DNA damage and the extent of its clinical manifesta-
tions in migraine may provide additional data to our
current knowledge.
Table 5 Comparison of oxidative stress parameters according to demographic variables
Demographic
variables
TAS (mmolTroloxEqv/L) p value TOS (mmolTroloxEqv/L) p value 8-OHdG (ng/mL) p value
Migraine Control (n = 35) Migraine Control Migraine Control
Smoking 1.88 ± 0.45 1.82 ± 0.52 0.798 5.21 ± 3.8 4.06 ± 3.4 0.091 4.12 ± 1.2 3.31 ± 1.8 0.001*
Non-smoking 1.9 ± 0.89 1.94 ± 0.7 0.892 4.86 ± 3.2 3.94 ± 3.1 0.064 3.96 ± 1.08 2.98 ± 1.2 0.001*
p value 0.639 0.017 0.768 0.518 0.465 0.662
Female 1.7 ± 0.38 1.88 ± 0.62 0.164 4.82 ± 3.9 3.86 ± 2.9 0.065 3.92 ± 1.3 2.92 ± 1.8 0.001*
Male 1.9 ± 0.45 1.92 ± 0.48 0.692 4.99 ± 3.4 4.01 ± 3.7 0.074 4.19 ± 1.1 3.38 ± 1.4 0.001*
p value 0.598 0.765 0.794 0.684 0.235 0.085
Drugs (+) 1.93 ± 0.17 – 5.48 ± 3.8 – 4.16 ± 1.2 –
Drugs (−) 1.85 ± 0.14 – 4.49 ± 2.8 – 3.99 ± 3.2 –
p value 0.103 0.290 0.336
Values are expressed as mean ± SD; TAS total antioxidant status, TOS total oxidant status, OSI oxidative stress ındex, 8-OHdG 8-hydroxy-2′-deoxyguanosine,
SD standard deviation *p < 0.05
Drug (+): Using symtometic migraine drugs (n = 24)
Drug (−): Not using symtometic migraine drugs (n = 26)
Table 6 Correlation analysis between migraine characteristics
and plasma indicators of oxidative stress
OHDG TAS TOS OSİ
(r/p) (r/p) (r/p) (r/p)
Disease duration 0.45/0.757 −0.275/0.053 0.152/0.293 −0.198/0.167
Frequency 0.195/0.175 −0.221/0.123 0.53/0.716 −0.42/0.776
MIDAS 0.204/0.154 −0.197/0.170 0.36/0.804 −0.046/0.753
Spearman’s rho correlation analysis was performed
Fig. 2 Correlation between 8-OHdG and TOS in MWA and MWoA
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reductase; GR: glutathione reductase; CAT: catalase.
Competing interests
The authors have no conflicts of interests related to this paper.
Authors’ contributions
SG conceived and designed the study. SG and EA were responsible for data
acquisition. SG, EA, MN and ST were in charge of data analysis and interpretation
and drafted the manuscript. MN and SG were responsible for critical revision of




1Department of Neurology, Gaziantep University, Gaziantep, Turkey. 2Division
Of Neurology, Turkish Ministry of Health Siirt State Hospital, Siirt, Turkey.
3Department of Biochemistry, Gaziantep University, Gaziantep, Turkey.
4Department of Neurology, Faculty of Medicine, University of Gaziantep,
Gaziantep 27130, Turkey.
Received: 16 January 2016 Accepted: 12 February 2016
References
1. Vurucu S, Karaoglu A, Paksu MS, Yesilyurt O, Oz O et al (2013) Relationship
between oxidative stress and chronic daily headache in children. Hum Exp
Toxicol 32:113–119
2. Cordero MD, Cano-Garcia FJ, Alcocer-Gomez E, De Miguel M, Sanchez-Alcazar
JA (2012) Oxidative stress correlates with headache symptoms in fibromyalgia:
coenzyme Q(1)(0) effect on clinical improvement. PLoS One 7, e35677
3. Neyal M, Yimenicioglu F, Aydeniz A, Taskin A, Saglam S et al (2013) Plasma
nitrite levels, total antioxidant status, total oxidant status, and oxidative
stress index in patients with tension-type headache and fibromyalgia.
Clin Neurol Neurosurg 115:736–740
4. Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbicer H (2008) Oxidative stress in
migraine with and without aura. Biol Trace Elem Res 126:92–97
5. Eren Y, Dirik E, Neselioglu S, Erel O (2015) Oxidative stress and decreased
thiol level in patients with migraine: cross-sectional study. Acta Neurol
Belg 115:643–649
6. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen
radicals in DNA damage and cancer incidence. Mol Cell Biochem 266:37–56
7. Carri MT, Valle C, Bozzo F, Cozzolino M (2015) Oxidative stress and mitochondrial
damage: importance in non-SOD1 ALS. Front Cell Neurosci 9:41
8. De Martinis BS, de Lourdes Pires Bianchi M (2002) Methodology for urinary
8-hydroxy-2′-deoxyguanosine analysis by HPLC with electrochemical
detection. Pharmacol Res 46:129–131
9. Long JD, Matson WR, Juhl AR, Leavitt BR, Paulsen JS et al (2012) 8OHdG as a
marker for Huntington disease progression. Neurobiol Dis 46:625–634
10. Isobe C, Abe T, Terayama Y (2010) Levels of reduced and oxidized
coenzyme Q-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid
of patients with living Parkinson’s disease demonstrate that mitochondrial
oxidative damage and/or oxidative DNA damage contributes to the
neurodegenerative process. Neurosci Lett 469:159–163
11. Neri M, Frustaci A, Milic M, Valdiglesias V, Fini M et al (2015) A meta-analysis
of biomarkers related to oxidative stress and nitric oxide pathway in
migraine. Cephalalgia 35:931–937
12. Benemei S, Fusi C, Trevisan G, Geppetti P (2014) The TRPA1 channel in
migraine mechanism and treatment. Br J Pharmacol 171:2552–2567
13. Borkum JM (2015) Migraine triggers and oxidative stress: a narrative review
and synthesis. Headache 56:12-35.
14. Headache Classification Committee of the International Headache S (2013)
The International Classification of Headache Disorders, 3rd edition (beta
version). Cephalalgia 33:629–808
15. Erel O (2004) A novel automated method to measure total antioxidant
response against potent free radical reactions. Clin Biochem 37:112–119
16. Erel O (2005) A new automated colorimetric method for measuring total
oxidant status. Clin Biochem 38:1103–1111
17. Erel O (2004) A novel automated direct measurement method for total
antioxidant capacity using a new generation, more stable ABTS radical
cation. Clin Biochem 37:277–285
18. Goadsby PJ (2012) Pathophysiology of migraine. Ann Indian Acad Neurol
15:S15–S22
19. Rajendran P, Nandakumar N, Rengarajan T, Palaniswami R, Gnanadhas EN et al
(2014) Antioxidants and human diseases. Clin Chim Acta 436:332–347
20. Alp R, Selek S, Alp SI, Taskin A, Kocyigit A (2010) Oxidative and antioxidative
balance in patients of migraine. Eur Rev Med Pharmacol Sci 14:877–882
21. Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C, Marini C, Ciancarelli I et al
(1997) Oxidative stress and platelet responsiveness in migraine. Cephalalgia
17:580–584
22. Doruk S, Ozyurt H, Inonu H, Erkorkmaz U, Saylan O et al (2011) Oxidative
status in the lungs associated with tobacco smoke exposure. Clin Chem Lab
Med 49:2007–2012
23. Bloomer RJ, Fisher-Wellman KH (2008) Blood oxidative stress biomarkers:
influence of sex, exercise training status, and dietary intake. Gend Med 5:218–228
24. Orhan H, Sahin G (2001) In vitro effects of NSAIDS and paracetamol on
oxidative stress-related parameters of human erythrocytes. Exp Toxicol
Pathol 53:133–140
25. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM (2002)
Elevated levels of oxidative DNA damage and DNA repair enzymes in
human atherosclerotic plaques. Circulation 106:927–932
26. Kanauchi M, Nishioka H, Hashimoto T (2002) Oxidative DNA damage and
tubulointerstitial injury in diabetic nephropathy. Nephron 91:327–329
27. Tabur S, Aksoy SN, Korkmaz H, Ozkaya M, Aksoy N et al (2015) Investigation
of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma.
Tumour Biol 36:2667–2674
28. Margaritelis NV, Veskoukis AS, Paschalis V, Vrabas IS, Dipla K et al (2015) Blood
reflects tissue oxidative stress: a systematic review. Biomarkers 20:97–108
Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Geyik et al. The Journal of Headache and Pain  (2016) 17:10 Page 6 of 6
